Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00718016 · ClinicalTrials.gov registry record

Assessment of the Cyberlink Control System for Use by the Amyotrophic Lateral Sclerosis (ALS) Patient

A clinical trial, sponsored by Drexel University College of Medicine.

Terminated
Registry status
1
Enrollment target

NCT00718016: Clinical Trial study, sponsored by Drexel University College of Medicine.

NCT00718016 is a clinical trial that was terminated before completion, run by Drexel University College of Medicine. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00718016 was terminated before completion, sponsored by Drexel University College of Medicine.

TERMINATED
Registry status
1 participants
Enrollment target

Study Summary

The goal of this project is to determine whether this device is a practical and realistic means for ALS patients to operate their computers with only the use of facial, brainwave, and eye movements. This study is intended to evaluate both the complexity of the system and the degree to which complications of ALS (such as severity of involuntary movements) may interfere with the use of cyberlink.

Primary Outcome

Reliability and accuracy of the Cyberlink System at the end of the 4th session will be used to assess overall usability of the system

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2004-12
Est. Completion 2009-04

Why NCT00718016 stopped before completion

NCT00718016 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT00718016 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00718016 about?

NCT00718016 is a clinical study titled "Assessment of the Cyberlink Control System for Use by the Amyotrophic Lateral Sclerosis (ALS) Patient". The goal of this project is to determine whether this device is a practical and realistic means for ALS patients to operate their computers with only the use of facial, brainwave, and eye movements. This study is intended to evaluate both the complexity of the system and the degree to which complica...

What is the current status of trial NCT00718016?

This trial is currently terminated. The enrollment target is 1 participants. The study started on 2004-12. Estimated completion is 2009-04.

Who is sponsoring clinical trial NCT00718016?

This trial is sponsored by Drexel University College of Medicine, which has 25 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00718016, the US trial registry maintained by the National Library of Medicine. NCT00718016 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.